within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AH02_Alvimopan;

model Alvimopan
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.06,
    Cl = 4.333333333333333e-06,
    adminDuration = 600,
    adminMass = 12 / 1000000,
    adminCount = 1,
    Vd = 0.030199999999999998,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0025166666666666666,
    Tlag = 10.020000000000001,
    Vdp = 0.0625,
    k12 = 7.611111111111111e-06,
    k21 = 7.611111111111111e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Alvimopan</td></tr><tr><td>ATC code:</td><td>A06AH02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>12</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>30.2</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15.6</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Alvimopan is a peripherally acting µ-opioid receptor antagonist used to accelerate the recovery of bowel function after bowel resection surgery. The drug reduces opioid-induced gastrointestinal side effects. It is approved for short-term inpatient use in adults undergoing bowel resection surgery.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Foss, JF, et al., &amp; Schmith, VD (2008). Pharmacokinetics of alvimopan and its metabolite in healthy volunteers and patients in postoperative ileus trials. <i>Clinical pharmacology and therapeutics</i> 83(5) 770–776. DOI:<a href=\"https://doi.org/10.1038/sj.clpt.6100292\">10.1038/sj.clpt.6100292</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17653140/\">https://pubmed.ncbi.nlm.nih.gov/17653140</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A06AH02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Alvimopan;
